ASX ANNOUNCEMENT Lumos to Present at 20 th Bioshares Biotech Summit MELBOURNE, Australia (7 August 2026) – Lumos Diagnostics Holdings Ltd (ASX:LDX, “Lumos” or the “Company”) a leader in rapid , point-of-care diagnostic technologies, is pleased to provide a copy of the...
Lumos to Present at 20th Bioshares Biotech Summit
Filed with ASX ·
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call6ix hasn’t read this filing yet.
Lumos Diagnostics Holdings Ltd. on 6ix
Earlier from Lumos Diagnostics
- Lumos Receives FebriDx Order from PHASE Scientific
- Lumos Secures Distribution for FebriDx in Romania
- Change of Director's Interest Notice - DW
- Section 708A Cleansing Statement
- Application for quotation of securities - LDX
Later from Lumos Diagnostics
- FY26 Annual Report
- FY26 Appendix 4E
- FY26 Full Year Results Announcement
- Appendix 4G and Corporate Governance Statement
- FebriDx Commercial Traction Continues Across US Accounts
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics